Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease
We will create a treatment protocol that fits your needs
It has various physiological functions, such as promoting insulin secretion and synthesis, stimulating -cell proliferation, inducing islet regeneration, inhibiting -cell apoptosis and glucagon release, delaying gastric emptying and controlling appetite, etc
Their ability to promote weight loss and glycemic control is comparable, Dr
It tends to be better for your health and your joints than not doing that